Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 1109-1120
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1109
Table 3 Long-term clinical outcomes of the two groups of patients

DTR (n = 31)
RY (n = 31)
P value
Food intake ratio (%)89.61 ± 14.7580.06 ± 17.600.031a
Gallbladder disease, n (%)0.038a
    Positive2 (6.5)8 (25.8)
    Negative29 (93.5)23 (74.2)
Visick grade, n (%)0.033a
    I18 (61.3)11 (35.4)
    II12 (35.5)14 (45.2)
    III1 (3.2)6 (19.4)
Weight (kg)
    Preoperative71.86 ± 12.7769.34 ± 13.140.447
    Pos 1m63.5 ± 11.7362.03 ± 11.340.618
    Pos 3m59.24 ± 11.7458.15 ± 10.840.704
    Pos 6m57.85 ± 10.2556.55 ± 10.900.631
Hemoglobin (g/L)
    Preoperative134.22 ± 22.05137.77 ± 18.490.495
    Pos 1m123.16 ± 15.84122.48 ± 12.160.849
    Pos 3m118.97 ± 11.39119.21 ± 8.390.925
    Pos 6m119.32 ± 16.68117.20 ± 11.450.561
Prealbumin (mg/L)
    Preoperative270.09 ± 48.0265.52 ± 41.410.689
    Pos 1m213.17 ± 56.55204.18 ± 41.680.479
    Pos 3m202.37 ± 57.15201.34 ± 44.370.937
    Pos 6m203.25 ± 36.66185.12 ± 45.440.089
Albumin (g/L)
    Preoperative42.51 ± 3.3542.20 ± 2.440.672
    Pos 1m40.80 ± 2.3140.25 ± 2.450.368
    Pos 3m40.43 ± 3.2139.93 ± 2.830.521
    Pos 6m40.45 ± 3.9139.66 ± 4.120.44